These include therapeutic antibodies like ABX-IL-8 and HuMax-IL-8 (BMS-986253), CXCR1/CXCR2 inhibitors, and p38 MAPK inhibitors. The authors emphasize the importance of addressing potential ...

69,123 ENA-78 Hepatic ischemia-reperfusion in rat Neutralizing ab Protective 69 CXCR2 Ventilator-induced lung injury in mouse Acid and LPS-induced ALI in mouse CXCR2 knockout CXCR2 inhibitor ...

Indeed, small-molecule antagonists to chemokine receptors, such as CXCR2, have been developed. [64] As new therapeutic approaches are considered and developed, attention needs to be paid to ...